Literature DB >> 25550853

Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma.

Ying Yu1, Libo Sun2, Na Ren3, Yunqian Li1, Li Rong4, Gang Zhao1.   

Abstract

F box only protein 8 (FBX8) is a novel component of F-box proteins which involved in the ubiquitin-dependent proteolytic pathway. Recent studies have revealed that FBX8 was unregulated in tumor cells and was closely associated with tumor progression and metastasis of other cancer, but little research has been done yet to test its usefulness as a prognostic marker in human glioma. In the present study, we investigated the expression of FBX8 in glioma tissues using immunohistochemical analysis and evaluated its prognostic significance in glioma. We found that 44/77 (57.14%) gilomas had positive expression of FBX8, while 65/77 (84.42%) normal brain tissue had positive expression of FBX8. The expression level of FBX8 was remarkably down-regulated in glioma tissues compared with normal brain tissues (P < 0.001). The down-expression of FBX8 in tumor cells was strongly correlated with tumor grade of patients with glioma (P < 0.05). Patients with lower expression of FBX8 protein had shorter overall survival time than those with higher level expression of FBX8 (P < 0.05). Multivariate analysis showed that FBX8 down-expression was an independent prognostic indicator for glioma patient's survival. Our results suggest that a potential application of FBX8 in prognosis prediction and therapeutic application in glioma.

Entities:  

Keywords:  F box only protein 8; glioma; prognosis; tumor grade

Mesh:

Substances:

Year:  2014        PMID: 25550853      PMCID: PMC4270539     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.

Authors:  R Masunaga; H Kohno; D K Dhar; S Ohno; M Shibakita; S Kinugasa; H Yoshimura; M Tachibana; H Kubota; N Nagasue
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

2.  Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival.

Authors:  Liang Zhao; Yawei Liu; Xuegang Sun; Minyi He; Yanqing Ding
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-29       Impact factor: 4.553

3.  Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.

Authors:  Xiangrong Chen; Weipeng Hu; Baoyuan Xie; Hongzhi Gao; Chaoyang Xu; Junyan Chen
Journal:  Biochem Biophys Res Commun       Date:  2014-04-29       Impact factor: 3.575

4.  cDNA cloning and expression analysis of new members of the mammalian F-box protein family.

Authors:  G P Ilyin; M Rialland; C Pigeon; C Guguen-Guillouzo
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

5.  Requirement for Arf6 in breast cancer invasive activities.

Authors:  Shigeru Hashimoto; Yasuhito Onodera; Ari Hashimoto; Miwa Tanaka; Michinari Hamaguchi; Atsuko Yamada; Hisataka Sabe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

6.  STAT3 silencing inhibits glioma single cell infiltration and tumor growth.

Authors:  Maike Priester; Ekaterini Copanaki; Vida Vafaizadeh; Sandra Hensel; Christian Bernreuther; Markus Glatzel; Volker Seifert; Bernd Groner; Donat Kögel; Jakob Weissenberger
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

7.  Fbx8 makes Arf6 refractory to function via ubiquitination.

Authors:  Hajime Yano; Itaru Kobayashi; Yasuhito Onodera; Frédéric Luton; Michel Franco; Yuichi Mazaki; Shigeru Hashimoto; Kazuhiro Iwai; Ze'ev Ronai; Hisataka Sabe
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

8.  ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway.

Authors:  Sarah E Tague; Vandhana Muralidharan; Crislyn D'Souza-Schorey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

9.  FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.

Authors:  Feifei Wang; Yudan Qiao; Jiang Yu; Xiaoli Ren; Jianmei Wang; Yi Ding; Xiaojing Zhang; Wenhui Ma; Yanqing Ding; Li Liang
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 10.  The F-box protein family.

Authors:  E T Kipreos; M Pagano
Journal:  Genome Biol       Date:  2000-11-10       Impact factor: 13.583

View more
  2 in total

1.  FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression.

Authors:  Wang FeiFei; Xu HongHai; Yan YongRong; Wu PingXiang; Wu JianHua; Zhu XiaoHui; Li JiaoYing; Sun JingBo; Zhou Kun; Ren XiaoLi; Qi Lu; Lan XiaoLiang; Cheng ZhiQiang; Tang Na; Liao WenTing; Ding YanQing; Liang Li
Journal:  Cell Death Dis       Date:  2019-04-25       Impact factor: 8.469

2.  FBX8 promotes metastatic dormancy of colorectal cancer in liver.

Authors:  Xiaohui Zhu; Feifei Wang; Xuehui Wu; Zhou Li; Zhizhi Wang; Xiaoli Ren; Yangshu Zhou; Fuyao Song; Yunshi Liang; Zhicheng Zeng; Wangjun Liao; Yanqing Ding; Wenting Liao; Li Liang
Journal:  Cell Death Dis       Date:  2020-08-14       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.